Not Just from Ethanol. Tetrahydroisoquinolinic (TIQ) Derivatives: from Neurotoxicity to Neuroprotection.


Journal

Neurotoxicity research
ISSN: 1476-3524
Titre abrégé: Neurotox Res
Pays: United States
ID NLM: 100929017

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 14 02 2019
accepted: 21 04 2019
revised: 29 03 2019
pubmed: 3 5 2019
medline: 13 5 2020
entrez: 4 5 2019
Statut: ppublish

Résumé

The 1,2,3,4-tetrahydroisoquinolines (TIQs) are compounds frequently described as alkaloids that can be found in the human body fluids and/or tissues including the brain. In most circumstances, TIQs may be originated as a consequence of reactions, known as Pictet-Spengler condensations, between biogenic amines and electrophilic carbonyl compounds, including ethanol's main metabolite, acetaldehyde. Several TIQs may also be synthesized enzymatically whilst others may be formed in the body as by-products of other compounds including TIQs themselves. The biological actions of TIQs appear critically dependent on their metabolism, and nowadays, among TIQs, 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol), N-methyl-1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (N-methyl-(R)-salsolinol), 1-[(3,4-dihydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol (norlaudanosoline or tetrahydropapaveroline or THP) and 1-benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ) are considered as those endowed with the most potent neurotoxic actions. However, it remains to be established whether a continuous exposure to TIQs or to their metabolites might carry toxicological consequences in the short- or long-term period. Remarkably, recent findings suggest that some TIQs such as (1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol) (higenamine) and 1-methyl-1,2,3,4-tetrahydroisoquinoline (1-MeTIQ) as well as N-methyl-tetrahydroisoquinoline (N-methyl-TIQ) exert unique neuroprotective and neurorestorative actions. The present review article provides an overview on these aspects of TIQs and summarizes those that presently appear the most significant highlights on this puzzling topic.

Identifiants

pubmed: 31049880
doi: 10.1007/s12640-019-00051-9
pii: 10.1007/s12640-019-00051-9
doi:

Substances chimiques

Isoquinolines 0
Neuroprotective Agents 0
Tetrahydroisoquinolines 0
Ethanol 3K9958V90M
1,2,3,4-tetrahydroisoquinoline 56W89FBX3E
salsolinol 9ILS801M65
Dopamine VTD58H1Z2X

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

653-668

Subventions

Organisme : MIUR
ID : FFABRPEANA2017

Références

Alcohol Clin Exp Res. 2010 Feb;34(2):242-50
pubmed: 19951298
Biochem Pharmacol. 1998 Oct 15;56(8):921-33
pubmed: 9776302
Pharmacol Rep. 2012;64(4):857-69
pubmed: 23087137
Pol J Pharmacol. 2002 Nov-Dec;54(6):567-72
pubmed: 12866710
J Neural Transm (Vienna). 1998;105(6-7):677-88
pubmed: 9826110
Int Immunopharmacol. 2006 Feb;6(2):226-33
pubmed: 16399627
Acta Biochim Biophys Sin (Shanghai). 2014 Nov;46(11):950-6
pubmed: 25274329
Eur Neurol. 1993;33 Suppl 1:60-8
pubmed: 8375435
Free Radic Biol Med. 2004 May 1;36(9):1185-94
pubmed: 15082072
Neurosci Lett. 2006 Feb 27;395(1):63-6
pubmed: 16289318
Front Behav Neurosci. 2013 May 24;7:52
pubmed: 23745110
Nat Protoc. 2007;2(1):141-51
pubmed: 17401348
Biochem Biophys Res Commun. 1997 Jul 30;236(3):676-81
pubmed: 9245712
Neurosci Lett. 2000 Apr 14;283(3):224-6
pubmed: 10754228
Front Behav Neurosci. 2017 Jan 23;10:253
pubmed: 28167903
Eur J Pharmacol. 2003 Apr 18;466(3):263-9
pubmed: 12694809
Behav Pharmacol. 2012 Feb;23(1):105-12
pubmed: 22157142
Alcohol. 1993 Mar-Apr;10(2):133-8
pubmed: 8442889
Brain Res. 1981 Nov 16;224(2):446-51
pubmed: 7284853
J Neurochem. 1990 Nov;55(5):1507-14
pubmed: 2213007
Expert Opin Ther Pat. 2017 Jan;27(1):17-36
pubmed: 27623022
Neurosci Lett. 1988 Feb 15;85(1):101-4
pubmed: 3362404
J Neurochem. 1996 Mar;66(3):1174-81
pubmed: 8769881
Neurotoxicology. 2004 Jan;25(1-2):193-204
pubmed: 14697894
Science. 1979 Dec 7;206(4423):1184-6
pubmed: 505002
Prog Neurobiol. 2004 Jun;73(3):151-77
pubmed: 15236834
Alcohol Clin Exp Res. 2000 Mar;24(3):366-72
pubmed: 10776678
Neurobiology (Bp). 2000;8(1):55-68
pubmed: 11008878
Neurosci Lett. 1999 Jan 15;259(3):157-60
pubmed: 10025582
Plant Biotechnol J. 2016 Jun;14(6):1319-28
pubmed: 26503307
Bioorg Med Chem. 2005 Jan 17;13(2):443-8
pubmed: 15598565
Neurogenetics. 2012 Feb;13(1):87-91
pubmed: 22238121
Drug Alcohol Depend. 1977 Sep-Nov;2(5-6):495-500
pubmed: 913244
Pharmacol Rep. 2017 Oct;69(5):851-860
pubmed: 28623709
Exp Neurobiol. 2010 Sep;19(2):63-70
pubmed: 22110343
Front Behav Neurosci. 2017 May 11;11:81
pubmed: 28553209
Res Commun Chem Pathol Pharmacol. 1980 Jan;27(1):3-16
pubmed: 6244607
Planta Med. 1984 Aug;50(4):343-5
pubmed: 6505087
J Neurosci. 1989 Nov;9(11):4051-61
pubmed: 2555461
Life Sci. 1988;43(4):373-8
pubmed: 3398705
Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):1989-93
pubmed: 7892213
J Neural Transm (Vienna). 2018 Apr;125(4):615-650
pubmed: 29222591
Int J Neuropsychopharmacol. 2004 Jun;7(2):155-63
pubmed: 14741061
Life Sci. 1997;60(2):79-89
pubmed: 9000113
Neurotox Res. 2018 Apr;33(3):523-531
pubmed: 29076060
Experientia. 1988 Sep 15;44(9):751-3
pubmed: 2843397
Biomed Environ Mass Spectrom. 1990 Jul;19(7):415-9
pubmed: 2205314
Life Sci. 1975 Feb 15;16(4):585-601
pubmed: 1168298
Biol Pharm Bull. 2005 Aug;28(8):1355-62
pubmed: 16079473
J Neurochem. 2001 Jul;78(1):100-8
pubmed: 11432977
Folia Biol (Praha). 2012;58(2):49-56
pubmed: 22578954
Pharmacol Biochem Behav. 1982 Oct;17(4):813-21
pubmed: 7178189
Psychopharmacology (Berl). 2010 Mar;209(1):1-11
pubmed: 20084370
Brain Res. 2010 Mar 19;1321:133-42
pubmed: 20114039
Neurosci Biobehav Rev. 2012 Jan;36(1):362-78
pubmed: 21802444
Pharmacol Biochem Behav. 2015 Nov;138:32-9
pubmed: 26366782
J Pharmacol Exp Ther. 1992 Mar;260(3):974-8
pubmed: 1545408
J Med Chem. 1992 Apr 17;35(8):1345-70
pubmed: 1533422
J Toxicol Sci. 2014;39(5):749-54
pubmed: 25242405
Planta. 2001 Oct;213(6):898-906
pubmed: 11722126
J Exp Neurosci. 2016 Nov 20;10:137-146
pubmed: 27891052
Plant Cell Physiol. 2013 May;54(5):647-72
pubmed: 23385146
Alcohol Clin Exp Res. 2009 Feb;33(2):206-19
pubmed: 19032583
J Ethnopharmacol. 2017 Jan 20;196:242-252
pubmed: 28007527
Neurosci Res. 1997 Oct;29(2):99-111
pubmed: 9359458
Bioorg Med Chem. 2017 Dec 15;25(24):6412-6416
pubmed: 29066136
Brain Res Bull. 2003 Apr 15;60(1-2):59-65
pubmed: 12725893
Pharmacology. 2015;95(1-2):87-94
pubmed: 25633935
Brain Pathol. 2002 Oct;12(4):499-510
pubmed: 12408237
Neurotox Res. 2018 Oct;34(3):706-716
pubmed: 30129004
ACS Chem Neurosci. 2018 Jun 20;9(6):1388-1398
pubmed: 29602279
Neurosci Lett. 1996 Jul 19;212(3):183-6
pubmed: 8843103
Addict Biol. 2015 Jan;20(1):182-93
pubmed: 24103023
Planta Med. 2002 Apr;68(4):326-9
pubmed: 11988856
Neurochem Int. 1992 Mar;20 Suppl:287S-293S
pubmed: 1365444
Proc Natl Acad Sci U S A. 2010 May 4;107(18):8147-52
pubmed: 20421505
Pol J Pharmacol. 2004 Nov-Dec;56(6):727-34
pubmed: 15662085
Int J Mol Sci. 2017 Nov 24;18(12):
pubmed: 29186770
Acta Pharmacol Sin. 2008 Oct;29(10):1187-94
pubmed: 18817623
Front Biosci (Landmark Ed). 2019 Mar 1;24:859-869
pubmed: 30844718
Nature. 1987 Dec 17-23;330(6149):674-7
pubmed: 3683586
J Neurol Sci. 1999 Apr 1;164(2):158-62
pubmed: 10402028
Clin Toxicol (Phila). 2019 Feb;57(2):125-130
pubmed: 30188222
Brain Res. 1985 Dec 9;358(1-2):122-8
pubmed: 4075110
Neurosci Biobehav Rev. 2012 Jan;36(1):404-30
pubmed: 21824493
Neurotoxicology. 2004 Jan;25(1-2):117-20
pubmed: 14697886
Neurochem Int. 2007 Jan;50(2):427-34
pubmed: 17141375
Psychopharmacol Bull. 1984 Summer;20(3):548-53
pubmed: 6332333
Psychopharmacology (Berl). 2015 Dec;232(23):4269-76
pubmed: 26292801
Science. 1970 Mar 27;167(3926):1749-51
pubmed: 5461272
Alcohol. 2014 Sep;48(6):551-9
pubmed: 25086835
Brain Res. 2004 May 29;1009(1-2):67-81
pubmed: 15120584
Science. 1970 Feb 13;167(3920):1005-7
pubmed: 5460776
Neurotox Res. 2014 Jan;25(1):1-12
pubmed: 23719903
Adv Neurol. 1993;60:207-11
pubmed: 8093578
Neurotox Res. 2017 Jul;32(1):94-106
pubmed: 28367606
Neurotoxicology. 1994 Fall;15(3):765-8
pubmed: 7854617
Nat Prod Rep. 2008 Feb;25(1):25-34
pubmed: 18250896
Biomed Pharmacother. 2019 Jan;109:2348-2356
pubmed: 30551494
Chem Pharm Bull (Tokyo). 1976 Jan;24(1):176-8
pubmed: 1269062
CNS Neurol Disord Drug Targets. 2015;14(6):716-26
pubmed: 26022266
Exp Ther Med. 2017 Jul;14(1):664-670
pubmed: 28672983
Alcohol Alcohol. 2018 May 1;53(3):344-349
pubmed: 29329422
Neurotox Res. 2018 Feb;33(2):485-514
pubmed: 29063289
Bioorg Med Chem Lett. 2008 Jul 15;18(14):4110-4
pubmed: 18556200
Neurotoxicol Teratol. 2002 Sep-Oct;24(5):579-91
pubmed: 12200189
Int J Pept Protein Res. 1994 Oct;44(4):342-7
pubmed: 7875936
Nutr Metab Cardiovasc Dis. 2013 Jun;23(6):487-504
pubmed: 23642930
J Neurochem. 2010 Sep 1;114(5):1291-301
pubmed: 20067570
Neurochem Res. 2013 Feb;38(2):356-63
pubmed: 23184185
Phytother Res. 2019 Mar;33(3):708-717
pubmed: 30648306
Life Sci. 1974 Jun 1;14(11):2247-57
pubmed: 4847815
J Pharmacol Exp Ther. 1973 Jan;184(1):119-28
pubmed: 4686001
Front Behav Neurosci. 2017 Apr 04;11:57
pubmed: 28420969
Food Chem Toxicol. 2016 Nov;97:23-39
pubmed: 27523294
Drug Test Anal. 2018 Jun;10(6):1017-1024
pubmed: 29084416
Sci Rep. 2016 May 18;6:26323
pubmed: 27189519
J Pharmacol Exp Ther. 1979 Apr;209(1):79-86
pubmed: 571017
Neurochem Int. 2009 Sep;55(4):187-92
pubmed: 19524107
JAMA. 1971 Dec 27;218(13):1909-11
pubmed: 4398939
Biochem Pharmacol. 2002 Mar 1;63(5):909-20
pubmed: 11911843
J Neural Transm. 1988;74(2):61-74
pubmed: 2976808
Front Behav Neurosci. 2013 Jun 21;7:71
pubmed: 23801948
J Neurochem. 1995 Dec;65(6):2633-8
pubmed: 7595560
Neurotoxicol Teratol. 2002 Sep-Oct;24(5):571-7
pubmed: 12200188
Chirality. 2016 Mar;28(3):169-80
pubmed: 26729048
J Chromatogr. 1980 Jul 11;183(1):17-24
pubmed: 7400260
Annu Rev Neurosci. 1999;22:123-44
pubmed: 10202534
Neurol Neurochir Pol. 1997 Sep-Oct;31(5):875-85
pubmed: 9513952
Front Pharmacol. 2016 Mar 21;7:59
pubmed: 27047378
Nature. 1973 Feb 16;241(5390):439-43
pubmed: 4705752
Neurotox Res. 2014 Oct;26(3):240-54
pubmed: 24842650

Auteurs

Alessandra T Peana (AT)

Department of Chemistry and Pharmacy, University of Sassari, Via Muroni, 23, I-07100, Sassari, Italy. apeana@uniss.it.

Valentina Bassareo (V)

Department of Biomedical Sciences, National Institute of Neuroscience, Cagliari section, Center of Excellence for the Study of Neurobiology of Addiction, University Campus, University of Cagliari, I-09042, Monserrato (Cagliari), Italy.

Elio Acquas (E)

Department of Life and Environmental Sciences, Center of Excellence for the Study of Neurobiology of Addiction, University Campus, University of Cagliari, I-09042, Monserrato (Cagliari), Italy. acquas@unica.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH